Close Menu

You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.

Home › Tools & Technology › PCR › Great Basin Preliminary Q4 Revenues Spike 39 Percent

Great Basin Preliminary Q4 Revenues Spike 39 Percent

Jan 24, 2017

NEW YORK (GenomeWeb) – Great Basin Scientific today reported preliminary fourth quarter revenue growth of 39 percent year over year.

For the three months ended Dec. 31, 2016, the firm posted $851,930 in revenues, up from $611,870 in the previous year.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Feb
23
Featured Webinar

After the Surge: Driving Sample Processing Efficiency of Coronavirus Samples

Sponsored by
Thermo Fisher Scientific

As the world continues to contend with coronavirus and a surge in the infection rate, labs are required to run more samples than ever before. 

Feb
24
Featured Webinar

Case Study: Rapid Development and Manufacturing Scaleup of a Point-of-Care COVID-19 Test

Sponsored by
SCHOTT MINIFAB

Developing a fully integrated consumable cartridge for an automated diagnostic platform is a significant challenge. More challenging still is developing such a cartridge in response to a deadly global virus pandemic amid market uncertainty and extraordinary time constraints. 

What's Popular?

In PCR

  1. At JP Morgan Conference, Quidel CEO Discusses Plan to Enter OTC Infectious Disease Test Market

  2. FDA Grants Emergency Use Authorization for SML Genetree Molecular Coronavirus Test

  3. Thermo Fisher Scientific to Acquire Mesa Biotech for Up to $550M

  4. BARDA Provides Additional Funding to DiaSorin Molecular for COVID-19 Tests

  5. Lucira Health Files for $115M IPO

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2021 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.